Biological significance of essential fatty acids

Journal of Association of Physicians of India

Volumn 54, Issue APR., 2006, Pages 309-319

  Das, U N ^a  

^a UND LIFE SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESSENTIAL FATTY ACID; LINOLEIC ACID; LINOLENIC ACID;

ARTERIOSCLEROSIS; ARTICLE; BIOSYNTHESIS; HUMAN; INFLAMMATION; METABOLIC SYNDROME X; METABOLISM; PATHOPHYSIOLOGY;

ALPHA-LINOLENIC ACID; ARTERIOSCLEROSIS; FATTY ACIDS, ESSENTIAL; HUMANS; INFLAMMATION; LINOLEIC ACID; METABOLIC SYNDROME X;

EID: 33645689650     PISSN: 00045772     EISSN: 00045772     Source Type: Journal    
DOI: None     Document Type: Article

References (99)

1. Das UN, Horrobin DF, Begin ME, Huang YS, Cunnane SC, Manku MS, Nassar BA. Clinical significance of essential fatty acids. Nutrition 1988;4:337-42.
2. Das UN. Essential fatty acids: Biology and their clinical implications. Asian Pacific J Pharmacol 1991;6:317-30.
3. Das UN. Tumoricidal action of cis-unsaturated fatty acids and its relationship to free radicals and lipid peroxidation. Cancer Lett 1991;56:235-43.
4. Das UN. Beneficial action(s) of eicosapentaenoic acid/docosahexaenoic acid and nitric oxide in systemic lupus erythematosus. Med Sci Res 1995;23:723-6.
5. Das UN, Mohan IK, Raju TR. Effect of corticosteroids and eicosapentaenoic acid/docosahexaenoic acid on pro-oxidant and anti-oxidant status and metabolism of essential fatty acids in patients with glomerular disorders. Prostaglandins Leukot Essen Fatty Acids 2001;65:197-203.
6. 2 to prevent human essential hypertension. Eur f Clin J Nutr 2004;58:195-203.
7. Das UN. Can perinatal supplementation of long chain polyunsaturated fatty acids prevent diabetes mellitus? Eur J Clin Nutrition 2003;57:218-26.
8. Das UN. A Perinatal Strategy for Preventing Adult Diseases: The Role of Long- Chain Polyunsaturated Fatty Acids. Kluwer Academic Publishers, Boston, 2002.
9. Friedman Z, Shochat SJ, Maisels MJ, Marks KH, Lamberth EL Jr. Correction of essential fatty acid deficiency in newborn infants by cutaneous application of sunflower-seed oil. Pediatrics 1976;58:650-4.
10. Skolnik P, Eaglstein WH, Ziboh VA. Human essential fatty acid deficiency: treatment by topical application of linoleic acid. Arch Dermatol 1977;113:939-41.
11. Gibson RA, Kneebone GM. Fatty acid composition of human colostrums and mature breast milk. Am J Clin Nutr 1981;34:252-7.
12. Horrobin DF. The regulation of prostaglandin biosynthesis by the manipulation of essential fatty acid metabolism. Rev Pure Appl Pharmacol Sci 1983;4:339-83.
13. Cantwell MM, Flynn MA, Cronin D, O'Neill JP, Gibney MJ. Contribution of foods to trans unsaturated fatty acid intake in a group of Irish adults. J Hum Nutr Diet 2005;18:377-85.
14. Lopez-Garcia E., Schultze MB, Meigs JB, Manson JE, Rifai N, Stampfer MJ, Willett WC, Hu FB. Consumption of trans fatty acids is related to plasma biomarkors of inflammation and endothelial dysfunction. J Nutr 2005;135:562-6.
15. Mozaffarian D, Pischon T, Hankinson SE, Rifai N, Joshipura K, Willett WC, Rimm EB. Dietary intake of trans fatty acids and systemic inflammation in women. Am Clin Nutr 2004;79:006-12.
16. Brenner RR. Nutritional and hormonal factors influencing desaturation of essential fatty acids. Prog Lipid Res 1982;20:41-8.
17. Cook HW. The influence of trans acids on desaturation and elongation of fatty acids. Lipids 1981;16:920-6.
18. 5 desaturases may be a factor predisposing to the development of insulin resistance syndrome. Prostaglandins Leukotrienes Essen Fatty Acids 2005;72:343-50.
19. Das UN. Long chain polyunsaturated fatty acids in the growth and development of the brain and memory. Nutrition 2003;19:62-5.
20. Das UN. Can memory be improved? A discussion on the role of ras, GABA, acetylcholine, NO, insulin, TNF-α, and long-chain polyunsaturated fatty acids in memory formation and consolidation. Brain and Development 2003;25:251-61.
21. Calderon F, Kim HY. Docosahexaenoic acid promotes neurite growth in hippocampal neurons. J Neurochem 2004;90: 979-88.
22. Das UN. Antibiotic-like action of essential fatty acids. Canadian Med Assoc J 1985;132:1985.
23. Das UN. Do unsaturated fatty acids function as endogenous anti-bacterial and anti- viral molecules? Am J Clin Nutr, in press.
24. Giamarellos-Bourboulis EJ, Mouktaroudi M, Adamis T. Koussoulas V, Baziaka F, Perrea D, Karavannacos PE, Giamarellou H. n-6 polyunsaturated fatty acids enhance the activities of ceftazidime and amikacin in experimental sepsis caused by multidrug-resistant Pseudomonas aeroginosa. Antimicrob Agents Chemother 2004;48:4713-7.
25. Kumar KV, Das UN. Effect of cis-unsaturated fatty acids, prostaglandins, and free radicals on angiotensin-converting enzyme activity in vitro. Proc Soc Exp Biol Med 1997;214: 374-9.
26. Okuda Y, Kawashima K, Sawada T, Tsurumaru K, Asano M, Suzuki S, Soma M, Nakajima T, Yamashita K. Eicosapentaenoic acid enhances nitric oxide production by cultured human endothelial cells. Biochem Biophys Res Commun 1997;232:487-91.
27. Kaergel E, Muller DN, Honeck H, Theuer J, Shagdarsuren E, Mullally A, Luft FC, Schunck W-H. P450-dependent arachidonic acid metabolism and angiotensin-II-induced renal damage. Hypertension 2002;40:273-9.
28. Gilroy DW. New insights into the anti-inflammatory actions of aspirin- induction of nitric oxide through the generation of epi-lipoxins. Mem Inst Oswaldo Cruz 2005; 100 Suppl 1: 49-54.
29. Wang W, Diamond SL. Does elevated nitric oxide production enhance the release of prostacyclin from shear stressed aortic endothelial cells? Biochem Biophys Res Commun 1997;233: 748-51.
30. Das UN. Can COX-2 inhibitors induced increase in cardiovascular disease risk be modified by essential fatty acids? J Assoc Physicians India 2005;53:623-7.
31. El-Sohemy A, Archer MC. Regulation of mevalonate synthesis in low density llpoproteln receptor knockout mice fed n-3 or n-6 polyunsaturated fatty acids. Lipids 1999;34:1.037-43.
32. Nakamura N, Hamazaki T, Jokaji H, Minami S, Kobayashi M. Effect of HMG-CoA roductase inhibitors on plasma polyunsaturated fatty acid concentration in patients with hyperlipidemia. Int J Clin Lab Res 1998;28:192-5.
33. Duncan RE, El-Sohemy A, Archer MC. Regulation of HMG-CoA reductase in MCF-7 cells by genistein, EPA, and DHA, alone arid in combination with mevastatin. Cancer Lett 2005;224:221-8.
34. El-Sohemy A, Archer MC. Regulation of mevalonate synthesis in rat mammary glands by dietary n-3 and n-6 polyunsaturated fatty acids. Cancer Res 1997;57:3685-7.
35. Das UN. Essential fatty acids, lipid peroxidation and apoptosis. Prostaglandins Leukot Essen Fatty Acids 1999;61: 157-164.
36. Das UN. Essential fatty acids as possible mediators of the actions of statins. Prostaglandins Leukot Essen Fatty Acids 2001;65:37-40.
37. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT). JAMA 2002;288:2998-3007.
38. Sparrow CP, Burton CA, Hernandez M, Mundt S, Hassing H, Patel S, Rosa R, Hermanowski-Vosatka A, Wang PR, Zhang D, Peterson L, Detmers PA, Chao YS, Wright SD. Simvastatin has anti-inflammatory and antiatherosclerotic activities independent of plasma cholesterol lowering. Arterioscler Thromb Vasc Biol 2001;21:1.15-21.
39. Pahan K, Sheikh FG, Namboodiri AM, Singh I. Lovastatin and phenylacetate inhibit the induction of nitric oxide synthase and cytokines in rat primary astrocytes, microglia, arid macrophages. J Clin Invest 1997;100:2671-9.
40. Bauer DC. HMG CoA reductase inhibitors and the skeleton: a comprehensive review. Osteoporos Int 2003;14:273-82.
41. Vogel G. Cholesterol-lowering drugs may boost bones. Science 1999;286:1825-6.
42. Briel M, Struder M, Glass TR, Bucher HC. Effects of statins on stroke prevention In patients with and without coronary heart disease: a meta-analysis of randomized controlled trials. Am J Med 2004;117:596-606.
43. Riboldi P, Gerosa M, Meroni PL. Statins and autoimmune diseases. Lupus 2005;14:765-8.
44. Levine L. Statins stimulate arachidonic acid release and prostaglandin I2 production in rat liver cells. Lipids Health Dis 2003;2:1.
45. Scott HD, Laake K. Statins for the prevention of Alzheimer's disease. Cochrane Database Syst Rev 2001;(4):CD003160.
46. Endros S, Ghorbani R, Kolloy VE, Georgilis K, Lonnemann G, van dor Meer JWM, Rogers TS, Klempner MS, Weber PC, Shaefer EJ, Wolff SM, Dinarollo LA. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med 1989;320:265-271.
47. Kumar GS, Das UN. Effect of prostaglandins and their precursors on the proliferation of human lymphocytes and their secretion of tumor necrosis factor and various interleukins. Prostaglandins Leukot Essen Fatty Acids 1994;50:331-4.
48. Kumar SG, Das UN, Kurnar KV, Madhavi, Das NP, Tan BKH. Effect of n-6 and n-3 fatty acids on the proliferation and secretion of TNF and IL-2 by human lymphocytes in vitro. Nutrition Res 1992;12:815 23.
49. Bhattacharya A, Rahman M, Banu J, Lawrence RA, McGuff HS, Garrett IR, Fischbach M, Fernandes G. Inhibition of osteoporosis in autoimmune disease prone MRL/Mpj-Fas(lpr) mice by N-3 fatty acids. J Am Coll Nutr 2005;24: 200-9.
50. Das UN. Essential fatty acids and osteoporosis. Nutrition 2000;16:286-290.
51. Hu FB, Bronner L, Willett WC, Stampfer MJ, Rexrode KM, Albert CM, Hunter D, Marison JE. Fish and omega-3 fatty acid intake arid risk of coronary heart disease in women. JAMA 2002;287:1815-21.
52. Lukiw WJ, Cui J-G, Marcheselli VL, Bodker M, Botkjaer A, Gotlinger K, Serhan CN, Bazan NG. A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease. J Clin Invest 2005;115:2774-83.
53. Calon F, Lim GP, Morihara T, Yang F, Ubeda O, Salem N Jr, Frautschy SA, Cole GM. Dietary n-3 polyunsaturated fatty acid depletion activates caspases and decreases NMDA receptors in the brain of a transgenic mouse model of Alzhelmer's. Eur J Neurosci 2005;22:617-26.
54. Sinclair HM. Essential fatty acids in perspective. Hum Nutr Clin Nutr 1984;38:245-60.
55. Nordoy A, Bonaa KH, Sandset PM, Hansen JB, Nilsen H. Effect of omega-3 fatty acids and simvastatin on hemostatic risk factors and postprandial hyperlipemia in patients with combined hyperlipemia. Arterioscler Thromb Vasc Biol 2000;20:259-65.
56. Das UN. From bench to the clinic: γ-linolenic acid therapy of human gliomas. Prostaglandins Leukot Essen Fatty Acids 2004;70:539-52.
57. Ajith TA, Harikumar KB, Thasna H, Sabu MC, Babitha NV. Proapoptotic and antitumor activities of the HMG-CoA reductase inhibitor, lovastatin, against Dalton's lymphoma ascites tumor in mice. Clin Chernica Acta, 2005, in press.
58. Lopez-Coviella I, Berse B, Krauss R, Thies RS, Blusztajn JK. Induction and maintenance of the neuronal cholinergic phenotype in the central nervous system by BMP-9. Science 2000;:289:313-316.
59. Hashimoto M, Tanabe Y, Fujii Y, Kokuta T, Shibata H, Shido O. Chronic administration of docosahexaenoic acid ameliorates the impairment, of spatial cognition learning ability in amyloid beta-infused rats. J Nutr 2005;135:549-5.
60. Bayorh MA, Ganafa AA, Eatman D, Walton M, Feuerstein GZ. Sirnvastatin and losartan enhance nitric oxide and reduce oxidative stress in salt-induced hypertension. Am J Hypertens 2005;18:1496-1502.
61. Hoffman M. A new role for gases: neurotransmission, Science 1991;252:1788.
62. Armour KE, Armour KJ, Gallagher ME, Godecke A, Helfrich MH, Reid DM, Ralston SH. Defective bone formation and anabolic response to exogenous estrogen in mice with targeted disruption of endothelial nitric oxide synthase. Endocrinology 2001;:142:760-6.
63. Das UN. Nitric oxide as the mediator of the antiosteoporotic actions of estrogen, statins, and essential fatty acids. Exp Biol Med (Maywood) 2002;227:88-93.
64. Edison RJ, Muenke M. Central nervous system and limb anomalies in case reports of first-trimester statin exposure. N Engl J Med 2004;350:1579-82.
65. Endres S, Ghorbani R, Kelley VE, Georgilis K, Lonnemann G, van der Meer JWM, Rogers TS, Klempner MS, Weber PC, Shaefer EJ, Wolff SM, Dinarello LA. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med 1989;320:265-271.
66. Kumar GS, Das UN. Effect of prostaglandins and their precursors on the proliferation of human lymphocytes and their secretion of tumor necrosis factor and various interleukins. Prostaglandins Leukot Essen Fatty Acids 1994;50:331-4.
67. Kumar SG, Das UN, Kumar KV, Madhavi, Das NP, Tan BKH. Effect, of n-6 and n-3 fatty acids on the proliferation and secretion of TNF and IL-2 by human lymphocytes in vitro. Nutrition Res 1992;12:815-23.
68. Lang CH, Dobrescu C, Bagby GJ. Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic glucose output. Endocrinology 1992;130:43-52.
69. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity arid insulin resistance. J Clin Invest 1995;95:2409-15.
70. Han Y, He T, Huang DR, Pardo CA, Ransohoff RM. TNF-alpha mediates SDF-1 alpha-induced NF-kappa B activation and cytotoxic effects in primary astrocytes. J Clin Invest 2001;:108:425-35.
71. Tracey KJ, Wei H, Manogue KR, et al. Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation. J Exp Med 1988;167:1211-27.
72. Das UN. Tumour necrosis factor/cachectin: biology and relevance to disease. J Assoc Physicians India 1991;39:201-4.
73. Lahdevirta J, Maury CP, Teppo AM, Repo H. Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome. Am J Med 1988;85:289-91.
74. Wallis RS, Amir-Tahmasseb M, Ellner JJ. Induction of interleukin 1 arid tumor necrosis factor by mycobacterial proteins: the monocyte western blot. Proc Natl Acad Sci USA 1990;87:3348-3352.
75. Beck SA, Smith KL, Tisdale MJ. Anti-cachectic and antitumor effect of eicosapentaenoic acid and its effect on protein turnover. Cancer Res 1991;51:6089-93.
76. Ramos EJ, Middleton FA, Laviano A, Sato T, Romanova I, Das UN, Chen C, Qi Y, Meguid MM. Effects of omega-3 fatty acid supplementation on tumor-bearing rats. J Am Coll Surg 2004;199:716-23.
77. Lihn AS, Richelsen B, Pedersen SB, Hangaard SB, Rathje GS, Madsbad S, Andersen O. Increased expression of TNF-alpha, IL-6, and IL-8 in HALS; implications for reduced adiponectin expression and plasma levels. Am J Physiol Endocrinol Metab 2003;285:E1072-E1080.
78. Miller J, Carr A, Emery S, Law M, Mallal S, Baker D, Smith D, Kaldor J, Cooper DA. HIV lipodystrophy: prevalence, severity and correlates of risk in Australia. HIV Med 2003;4:293-301.
79. Huang Y-J, Fang VS, Chou Y-C, Kwok C-F, Ho L-T. Amelioration of insulin resistance and hypertension in a fructose-fed rat model with fish oil supplementation. Metabolism 1997;46:1252 8.
80. Mori Y, Murakawa Y, Katoh S, Hata S, Yokoyama J, Tajima N, Ikeda Y, Nobukata H, Ishikawa T, Shibutani Y. Influence of highly purified eicosapentaenoic acid ethyl ester on insulin resistance in the Otsuka Long-Evans Tokushima fatty rat, a model of spontaneous non-insulin-dependent diabetes mellitus, Metabolism 1997;46:1458-64.
81. Nobukata H, Ishikawa T, Obata M, Shibutani Y. Long-term administration of highly purified eicosapenlaenoic acid ethyl ester prevents diabetes and abnormalities of blood coagulation in male WBN/Kob rats. Metabolism 2000;49: 912-9.
82. Flachs P, Mohamed-Ali V, Horakova O, Rossmeisl M, Hosseinzadeh-Attar MJ, Hensler M, Ruzickova J, Kopecky J. Polyunsaturated fatty acids of marine origin induce adiponectin in mice fed a high-fat diet. Diabetologia 2006, in press.
83. Claria J, Serhan CN. Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions. Proc Natl Acad Sci USA 1995;92:9475-9.
84. Serhan CN, Hong S, Gronert K, Colgan SP, Devchand PR, Mirick G, Moussignac R-L. Resolvins: A family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J Exp Med 2002;196:1025-1037,
85. Marcheselli VL, Hong S, Lukiw WJ, Tian XH, Gronet K, Musto A, Hardy M, Gimenez JM, Chiang N, Serhan CN, Bazan NG. Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression. J Biol Chem 2003;278:43807-17.
86. Mukherjee PK, Marcheselli VL, Serhan CN, Bazan NG. Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress. Proc Natl Acad Sci USA 2004;101: 8491-6.
87. Gronert K, Maheshwari N, Khan N, Hasan IR, Dunn M, Laniado Schwartzman M. A role for the mouse 12/15-lipoxygenase pathway in promoting epithelial wound healing and host defense. J Biol Chem 2005;280:15267-78.
88. Kambe T, Murakami M, Kudo I. Polyunsaturated fatty acids potentiate interleukin-1-stimulated arachidonic acid release by cells overexpressing type IIA secretory phospholipase A2. FEBS Lett 1999;453:81-4.
89. 2 isoforms in the checkpoint control of acute inflammation. FASEB J 2004;18:489-98.
90. Das, U. N. Polyunsaturated Tally acids, endothelial lipase and atherosclerosis. Prostaglandins Leukot Essen Fatty Acids 2005;72:173 9.
91. Das, U. N. Pathophysiology of metabolic syndrome X and its links to the perinatal period. Nutrition 2005;21:762-73.
92. Forman BM, Chen J, Evans RM. Hypolipidomic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for poroxisome proliferator-activated receptors alpha and delta. Proc Natl Acad Sci USA 1997;94:4312-7.
93. Reseland JE, Haugen F, Hollung K, Solvoll K, Halvorsen B, Brude IR, Nenseter MS, Christiansen EN, Drevon CA. Reduction of leptin gene expression by dietary polyunsaturated fatty acids. J Lipid Res 2001;42:743-750.
94. Borkman M, Storlien LH, Pan DA, Jenkins AB, Chisholm DJ, Campbell LV. The relation between insulin sensitivity and the fatty-acid composition of skeletal-muscle phospholipids. N Engl J Med 1993;328:238-44.
95. Das UN. Essential fatty acid metabolism in patients with essential hypertension, diabetes mellitus and coronary heart disease. Prostaglandins Leukot Essen Fatty Acids 1995;52: 387-91.
96. Das UN, Kumar KV, Ramesh G. Essential fatty acid metabolism in South Indians. Prostaglandins Leukot Essen Fatty Acids 1994;50:253-5.
97. Aravindakshan M, Ghate M, Ranjekar PK, Evans DR, Mahadik SP. Supplementation with a combination of omega-3 fatty acids and antioxidants (vitamins E and C) improves the outcome of schizophrenia. Schizophr Res 2003;62:195-204.
98. Morris MC; Evans DA, Tangney CC, Bienias JL, Wilson RS. Fish consumption and cognitive decline with age in a large community study. Arch Neurol 2005;62:1-5.
99. Das UN, Vaddadi KS. Essential fatty acids in Huntington's disease. Nutrition 2004;20:942-7